Form 4 for SPTX Seaport Therapeutics, Inc.
Accepted 2026-05-04 18:06:29 ET · period of report 2026-04-30 · accession 0001193125-26-204468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-05-04 18:06 | 2026-05-04 | SPTX | Torres Denice | Dir | C - Cnv Deriv | — | +13.4K | 13.4K | New | — |
| D | 2026-05-04 18:06 | 2026-04-30 | SPTX | Torres Denice | Dir | A - Grant | $0.00 | +12.3K | 12.3K | New | $0 |
| DI | 2026-05-04 18:06 | 2026-05-04 | SPTX | Torres Denice | Dir | C - Cnv Deriv | $0.00 | -42.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-04 | C | A | 13,406 | — | 13,406 | I By Denice M. Torres Revocable Trust | — | — | (F1) Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-one basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering on May 4, 2026 without payment of further consideration. The Preferred Stock had no expiration date. (F2) The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of her pecuniary interest therein, if any. This report shall not be deemed an admission that she is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-04-30 | A | A | 12,258 | $0.00 | 12,258 | D | $18.00 · — to 2036-04-29 | 12,258 Common Stock | (F3) The shares underlying this option shall vest in full on April 30, 2027, subject to the Reporting Person's continued service on such vesting date. |
| 3 | Derivative | Series B Preferred Stock | 2026-05-04 | C | D | 42,105 | $0.00 | 0 | I By Denice M. Torres Revocable Trust | — · — to — | 13,406 Common Stock | (F1) Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-one basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering on May 4, 2026 without payment of further consideration. The Preferred Stock had no expiration date. (F1) Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-one basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering on May 4, 2026 without payment of further consideration. The Preferred Stock had no expiration date. (F1) Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-one basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering on May 4, 2026 without payment of further consideration. The Preferred Stock had no expiration date. (F2) The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of her pecuniary interest therein, if any. This report shall not be deemed an admission that she is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. |